Instil Bio

company

About

Instil Bio is a biotechnology company that develops cell therapies for solid tumor cures.

Details

Last Funding Type
Series A
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Life Science,Medical
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:TIL
Legal Name
Instil Bio, Inc.

Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes for the treatment of solid tumor cancers. It is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its candidate and the first-in-human study of its next-generation engineered TIL.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$520.20M
Instil Bio has raised a total of $520.20M in funding over 2 rounds. Their latest funding was raised on Mar 19, 2021 from a IPO round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 19, 2021 IPO $320M Detail
Dec 29, 2020 Series C 1 Detail
Aug 3, 2020 Series B $170.20M Detail
Jun 29, 2020 Series B $5M Detail
Mar 4, 2019 Series A $25M Detail

Investors

Number of Lead Investors
Number of Investors
1
Instil Bio is funded by 1 investors. HBM Healthcare Investments AG are the most recent investors.
Investor Name Lead Investor Funding Round
HBM Healthcare Investments AG Series C

Employee Profiles

Number of Employee Profiles
6
Instil Bio has 6 current employee profiles, including Executive Bronson Crouch
Executive
Executive
Executive
Executive
Employee